Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Intercare DX Inc (CE) | ICCO | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0884 | 0.0884 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.0171 - 0.0884 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.0884 | USD |
Intercare DX Inc (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 6.70M | 75.80M | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Intercare DX (CE) News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ICCO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.0183 | 0.0884 | 0.0183 | 0.0362058 | 4,687 | 0.0701 | 383.06% |
6 Months | 0.038 | 0.0884 | 0.0171 | 0.0285281 | 9,150 | 0.0504 | 132.63% |
1 Year | 0.028 | 0.0884 | 0.0171 | 0.0282806 | 10,021 | 0.0604 | 215.71% |
3 Years | 0.0595 | 0.212 | 0.0171 | 0.1186797 | 73,811 | 0.0289 | 48.57% |
5 Years | 0.0065 | 0.212 | 0.00645 | 0.0960277 | 69,807 | 0.0819 | 1,260.00% |
Intercare DX (CE) Description
InterCare Dx, Inc., is a USFDA registered biomedical and life sciences company with main office located at 20300 South Vermont Avenue, Suite 215, Torrance, California, USA, and international partners located worldwide.We have also developed an Integrated, web-enabled applications target towards (a) Education Management, (b) Hospitality Management,(c) Legal System Management,(d) Human Capital Management and (e) Telemedicine and Telehealth Solutions. In addition, we designed, developed and commercialized the "The Mirage Systems Biofeedback and Self Regulation Software Program", the first USFDA approved Software only biofeedback program for clinical use. This product was licensed to United States Navy Submarine division in San Diego California in 1995 and a research center in Germany We have also Commercialized "Vascular Diagnostic Center (Vasocor Model 300)", a freestanding diagnostic device that employs a revolutionary non-invasive, inexpensive, easy-to- use procedure that has been clinically proven to detect coronary artery disease ("CAD") earlier and more accurately than existing techniques. Users include primary care physicians, cardiologists, vascular specialists, clinics, and hospitals. The device is simple enough to be operated by non-physicians and non-nurses. Further, the Vasocor device has FDA approval, validated clinical trial data and qualified for Medicare reimbursement. |